Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Neridronate

Phase 3Small molecule

AAmbros Therapeutics, Inc.

1

Indications

4

Total Trials

2

Active Trials

0

Competitors

Pipeline

Status by Indication[3][1]

Indication

Complex Regional Pain Syndrome Type IRecruiting

Complex Regional Pain Syndrome Type IPhase 3

Recruiting

Timeline

Expected Milestones

Q1 2028

Phase 3Recruiting

Complex Regional Pain Syndrome Type I

NCT07210515

Q1 2029

Phase 3Recruiting

Complex Regional Pain Syndrome Type I

NCT07857733

Clinical

Trials by Indication[1]

Complex Regional Pain Syndrome Type I2 trials

A Randomized, Triple-blind, Placebo-controlled, Phase 3 Trial to Evaluate the Efficacy, Safety, and Tolerability of Intravenous AMBTX-01 (Neridronate) for Treatment of Complex Regional Pain Syndrome Type 1 (CRPS-RISE)

Recruiting·AAmbros Therapeutics, Inc.·Phase 3·NCT07210515·270 enrolled

An Open-Label, Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of Intravenous AMBTX-01 (Neridronate) for the Treatment of Complex Regional Pain Syndrome Type 1

Recruiting·AAmbros Therapeutics, Inc.·Phase 3·NCT07857733·135 enrolled

Osteoporosis1 trial

Efficacy and Safety of Neridronate (Nerixia®)to Treat Osteoporosis in Patients With TM and TI

Completed·EEnte Ospedaliero Ospedali Galliera·Phase 2·NCT01140321·120 enrolled

Osteoarthritis1 trial

Efficacy Study of Neridronate to Treat Painful Osteoarthritis of the Knee With Bone Marrow Lesions.

Unknown status·AASST Gaetano Pini-CTO·Phase 2·NCT01803360·60 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for Neridronate. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Neridronate compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Neridronate. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Ambros Therapeutics, Inc. company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: AAmbros Therapeutics, Inc.

Related News